After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Bicara Therapeutics Inc is $641.19M. A total of 0.55 million shares were traded on the day, compared to an average of 469.18K shares.
In the most recent transaction, Meisner Lara sold 79,146 shares of BCAX for 12.90 per share on Mar 14 ’25. After the transaction, the Chief Legal Officer now owns 0 company shares. In a previous transaction on Mar 14 ’25, LARA S. MEISNER bought 79,146 shares at 13.35 per share.
Among the insiders who bought shares, RA CAPITAL MANAGEMENT, L.P. acquired of 1,833,000 shares on Sep 16 ’24 at a per-share price of $18.00. This resulted in the Director holding 4,303,418 shares of BCAX after the transaction. In another insider transaction, Flynn James E bought 70,000 shares at $18.00 per share on Sep 17 ’24. Company shares held by the Possible Members of 10% Group now total 897,587.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, BCAX has a high of $28.09 and a low of $8.91.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BCAX is Buy with a score of 5.00.
